VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B

World News: . []

CAMBRIDGE Mass Dec 06 2018 GLOBE NEWSWIRE -- VBI Vaccines Inc NASDAQ VBIV VBI a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines today announced that it ente red int...

More news and information about VBI Vaccines, Inc.

Published By:

Globe Newswire: 13:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "vaccines" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us